ZAP-70 expression in ALL cases evaluated by immunocytochemistry
. | ZAP-70 positivity, no. positive/total (%) . |
|---|---|
| Immunophenoptypic results | |
| Pro-B ALL | 3/6 (50) |
| Common ALL | 13/25 (52) |
| Pre-B ALL | 5/6 (83) |
| Mature B-ALL | 2/2 (100) |
| Molecular abnormalities | |
| ALL1/AF4 | 0/3 (0) |
| BCR/ABL | 5/10 (50) |
| TEL/AML1 | 1/1 (100) |
| E2A/PBX1 | 1/1 (100) |
| No molecular abnormalities | 14/22 (64) |
. | ZAP-70 positivity, no. positive/total (%) . |
|---|---|
| Immunophenoptypic results | |
| Pro-B ALL | 3/6 (50) |
| Common ALL | 13/25 (52) |
| Pre-B ALL | 5/6 (83) |
| Mature B-ALL | 2/2 (100) |
| Molecular abnormalities | |
| ALL1/AF4 | 0/3 (0) |
| BCR/ABL | 5/10 (50) |
| TEL/AML1 | 1/1 (100) |
| E2A/PBX1 | 1/1 (100) |
| No molecular abnormalities | 14/22 (64) |
Samples are subdivided according to the immunophenotypic characteristics and molecular abnormalities.